ClinicalTrials.Veeva

Menu

E-health-supported Diagnostic and Intervention in Preterm Born Children and Their Families (NeoUp2)

U

University Hospital Tuebingen

Status

Enrolling

Conditions

Preterm Birth

Treatments

Other: Treatment as usual-Group (TAU)
Other: Intervention Group (APP)

Study type

Interventional

Funder types

Other

Identifiers

NCT06939192
652/2023BO2

Details and patient eligibility

About

The app-based diagnostic and support approach with a focus on mental and somatic symptoms is intended to strengthen the resilience of premature born children and families and to identify risk and resilience factors.The overall objective of the study is to improve the post-inpatient care of families with premature born children. The procedure is evaluated by a two-arm design with an experimental group and a TAU group.

Full description

The project aims to conduct a longitudinal study of premature babies and their parents from the time of hospital discharge in order to identify predictive factors for their psychological and physical outcomes and to provide individualized interdisciplinary diagnostic and treatment. The project helps to identify risk and protective factors and also takes a closer look at the interplay between the mind and body. This care approach is supported by an app that records symptoms and needs and also allows contact with the study team. The app also provides psychoeducational materials. The study was developed in collaboration with affected families and experts from the aftercare team. The concept will be evaluated by comparing the treatment group with a TAU group and by conducting measurements after hospital discharge, after 4 months, and again after 7 months, as well as through focus groups with study participants.

Enrollment

60 estimated patients

Sex

All

Ages

28 to 34 weeks old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Premature babies born at the UKT,
  • Gestational age 28-34 weeks,
  • Mother: age ≥ 18 years,
  • agreement to participate in this study and signing of a consent form,
  • sufficient knowledge of German,
  • internet access

Exclusion criteria

  • Premature babies < 28th or >34th week of pregnancy,
  • at least one of the children has serious diseases of the nervous system or obvious symptoms of a nervous disease,
  • at least one of the children has serious congenital diseases or suffers from malformations,
  • Mother: Lack of access to a smartphone/tablet,
  • no internet access,
  • insufficient knowledge of German

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 2 patient groups

Intervention Group (APP)
Experimental group
Description:
The participants in the intervention group will be equipped with an app after inclusion in the study. The app contains specific information for parents with premature babies, a contact form for experts and questions about the child's development every 14 days.
Treatment:
Other: Intervention Group (APP)
Treatment as usual Group (TAU)
Active Comparator group
Description:
Participants in the treatment as usual group do not receive an app after inclusion in the study. They can contact their pediatrician if they have any questions.
Treatment:
Other: Treatment as usual-Group (TAU)

Trial contacts and locations

1

Loading...

Central trial contact

Annette Conzelmann, Prof. Dr.; Annette Conzelmann, Prof.Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems